Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Competitive Revision for Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness

NCT04634279 is registered in ClinicalTrials.gov with RAND as lead sponsor.

NCT NCT04634279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04634279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Competitive Revision for Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness
Lead sponsor
RAND
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2022
Completion date
June 12, 2024
Enrollment
68 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

addiction, depression, opioid-use disorder, post traumatic stress disorder, suicidal ideation